Daniela Santarelli is an accomplished pharmaceutical regulatory affairs specialist with over a decade of experience in the industry. She holds a Master of Science in Management from Sda Bocconi and studied Chemistry at Università Di Pisa. Her professional background includes working at renowned companies like Amgen, Ipsen, Jannsen Cilag Spa, Intermune, Lundbeck Italia, and Alexion Pharmaceuticals.

Daniela Santarelli has held various senior leadership roles in regulatory affairs, corporate and public affairs, clinical quality assurance, and market access. Her skills and expertise include market access strategy, regulatory strategy, product registration, clinical trials, and pharmaceutical compliance.

In her current role as Director, Market Access at Alexion Pharmaceuticals, Inc., Daniela leads market access initiatives for the company's portfolio of drugs across Europe, the Middle East, and Africa. Her prior work at Lundbeck Italia and Intermune involved driving regulatory and public affairs, pricing, and reimbursement strategy, while at Amgen, she focused on regulatory affairs management.

Overall, Daniela Santarelli is a pharmaceutical industry expert who has made significant contributions to regulatory affairs and market access. Her skills and insights are highly valued by the companies she has worked for.